로딩 중…
지수 로딩 중…
Aktis Oncology, Inc.
AKTS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$24.09+2.38%
2026-06-18
Price Chart
Aktis Oncology, Inc.
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.33B |
| Revenue | $6M |
| Net Income | $-64M |
| Total Assets | $265M |
| Net Assets | $-146M |
| Value | |
| P/S | 204.96x |
| FCF Yield | -5.54% |
| Profitability | |
| ROA | -24.06% |
| Op. Margin | -1149.52% |
| Revenue Growth | 336.92% |
| Financial Health | |
| Total Debt | $12M |
| FCF | $-74M |
| Cash | $38M |
| Current Ratio | 7.37x |
| Performance | |
| 1M Return | 30.22% |
| From 52W High | -17.39% |
| 1Y MDD | -32.19% |
| Trading | |
| Volume | 535,667 shares |
| Trading Value | $13M |